144 related articles for article (PubMed ID: 19457992)
1. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.
Huang L; Sayer JM; Swinford M; Louis JM; Chen C
J Virol; 2009 Aug; 83(15):7789-93. PubMed ID: 19457992
[TBL] [Abstract][Full Text] [Related]
2. Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.
Huang L; Hall A; Chen C
Retrovirology; 2010 Mar; 7():24. PubMed ID: 20331855
[TBL] [Abstract][Full Text] [Related]
3. Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions.
Huang L; Li Y; Chen C
Retrovirology; 2011 Oct; 8():79. PubMed ID: 21985091
[TBL] [Abstract][Full Text] [Related]
4. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C
PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662
[TBL] [Abstract][Full Text] [Related]
5. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
Agniswamy J; Sayer JM; Weber IT; Louis JM
Biochemistry; 2012 Feb; 51(5):1041-50. PubMed ID: 22242794
[TBL] [Abstract][Full Text] [Related]
6. Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.
Tang C; Louis JM; Aniana A; Suh JY; Clore GM
Nature; 2008 Oct; 455(7213):693-6. PubMed ID: 18833280
[TBL] [Abstract][Full Text] [Related]
7. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
Louis JM; Clore GM; Gronenborn AM
Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
9. Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.
Tien C; Huang L; Watanabe SM; Speidel JT; Carter CA; Chen C
PLoS One; 2018; 13(1):e0191372. PubMed ID: 29338056
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
Zybarth G; Kräusslich HG; Partin K; Carter C
J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734
[TBL] [Abstract][Full Text] [Related]
11. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.
Zybarth G; Carter C
J Virol; 1995 Jun; 69(6):3878-84. PubMed ID: 7745738
[TBL] [Abstract][Full Text] [Related]
12. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
[TBL] [Abstract][Full Text] [Related]
13. Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.
Park JH; Sayer JM; Aniana A; Yu X; Weber IT; Harrison RW; Louis JM
Biochemistry; 2016 Apr; 55(16):2390-400. PubMed ID: 27039930
[TBL] [Abstract][Full Text] [Related]
14. Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.
Louis JM; Deshmukh L; Sayer JM; Aniana A; Clore GM
Biochemistry; 2015 Sep; 54(35):5414-24. PubMed ID: 26266692
[TBL] [Abstract][Full Text] [Related]
15. Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.
Huang L; Chen C
AIDS Res Ther; 2010 Jul; 7():27. PubMed ID: 20667109
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant.
Dautin N; Karimova G; Ladant D
J Virol; 2003 Aug; 77(15):8216-26. PubMed ID: 12857890
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor.
Sayer JM; Aniana A; Louis JM
J Mol Biol; 2012 Sep; 422(2):230-44. PubMed ID: 22659320
[TBL] [Abstract][Full Text] [Related]
18. Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: relevance to drug resistance.
Sayer JM; Agniswamy J; Weber IT; Louis JM
Protein Sci; 2010 Nov; 19(11):2055-72. PubMed ID: 20737578
[TBL] [Abstract][Full Text] [Related]
19. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
Chiu HC; Wang FD; Chen YA; Wang CT
J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
[TBL] [Abstract][Full Text] [Related]
20. Understanding HIV-1 protease autoprocessing for novel therapeutic development.
Huang L; Chen C
Future Med Chem; 2013 Jul; 5(11):1215-29. PubMed ID: 23859204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
